Profile data is unavailable for this security.
About the company
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
- Revenue in JPY (TTM)768.50m
- Net income in JPY-1.28bn
- Incorporated1995
- Employees98.00
- LocationMedinet Co Ltd9F, TRC Center Bldg., 6-1-1, HeiwajimaOTA-KU 143-0006JapanJPN
- Phone+81 366311201
- Fax+81 366311202
- Websitehttps://www.medinet-inc.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veritas In Silico Inc | 246.24m | -148.31m | 5.87bn | 15.00 | -- | 2.55 | -- | 23.84 | -23.92 | -23.92 | 38.93 | 354.61 | 0.1227 | -- | -- | 16,415,930.00 | -7.39 | -- | -7.65 | -- | -- | -- | -60.23 | -- | 67.03 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.40bn | -1.51bn | 5.94bn | 67.00 | -- | 2.11 | -- | 4.24 | -85.98 | -85.98 | 80.34 | 147.09 | 0.391 | 1.19 | 13.59 | 20,922,580.00 | -42.15 | -14.45 | -45.45 | -16.95 | 87.53 | 90.59 | -107.80 | -35.42 | 11.11 | -- | 0.0215 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Noile-Immune Biotech Inc | 8.12m | -1.07bn | 7.27bn | 28.00 | -- | 1.48 | -- | 896.12 | -24.64 | -24.64 | 0.1875 | 113.23 | 0.0015 | 0.0229 | 0.0283 | 289,928.60 | -19.15 | -- | -19.61 | -- | 95.58 | -- | -13,139.53 | -- | 79.60 | -- | -- | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| OncoTherapy Science, Inc. | 478.75m | -1.12bn | 8.15bn | 54.00 | -- | 8.15 | -- | 17.02 | -4.86 | -4.86 | 2.04 | 3.68 | 0.3526 | 4.34 | 9.77 | 8,865,722.00 | -82.71 | -55.67 | -106.53 | -63.82 | -32.12 | -1.49 | -234.61 | -247.47 | 3.11 | -- | 0.0731 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| TMS Co Ltd | 0.00 | -1.10bn | 8.27bn | 14.00 | -- | 2.77 | -- | -- | -28.37 | -28.37 | 0.00 | 74.10 | 0.00 | -- | -- | 0.00 | -33.57 | -- | -34.42 | -- | -- | -- | -- | -- | 31.13 | -- | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
| Linical Co Ltd | 11.67bn | -121.16m | 8.54bn | 662.00 | -- | 1.06 | 20.77 | 0.7314 | -5.36 | -5.36 | 516.67 | 326.90 | 0.6575 | -- | 3.74 | 17,628,030.00 | -0.6826 | 4.01 | -1.18 | 6.33 | 26.63 | 30.99 | -1.04 | 5.48 | -- | 2.65 | 0.2588 | 50.81 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
| Modalis Therapeutics Corp | 0.00 | -1.87bn | 9.23bn | 37.00 | -- | 3.00 | -- | -- | -52.79 | -52.79 | 0.00 | 44.35 | 0.00 | -- | -- | 0.00 | -74.95 | -29.19 | -78.46 | -30.02 | -- | -- | -- | -597.35 | 43.87 | -87.46 | 0.0771 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| Chiome Bioscience Inc | 581.07m | -1.22bn | 9.37bn | 51.00 | -- | 7.56 | -- | 16.12 | -22.07 | -22.07 | 10.53 | 19.85 | 0.3371 | 5.16 | 8.01 | 11,393,550.00 | -70.61 | -50.50 | -95.97 | -57.38 | 53.55 | 57.53 | -209.45 | -224.74 | 3.57 | -894.37 | 0.1995 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Medinet Co Ltd | 768.50m | -1.28bn | 10.58bn | 98.00 | -- | 2.04 | -- | 13.77 | -5.04 | -5.04 | 3.05 | 19.62 | 0.1356 | 11.15 | 3.46 | -- | -22.53 | -21.15 | -23.83 | -22.39 | 14.66 | 22.97 | -166.17 | -160.19 | 18.45 | -- | 0.0002 | -- | 16.17 | -6.21 | 11.19 | -- | -11.16 | -- |
| 3-D Matrix Ltd | 5.25bn | -1.05bn | 11.06bn | 106.00 | -- | 9.52 | -- | 2.11 | -12.89 | -12.89 | 66.88 | 11.66 | 0.8559 | 0.551 | 5.40 | 49,502,420.00 | -17.15 | -42.10 | -21.31 | -55.60 | 68.38 | 53.95 | -20.04 | -96.03 | 2.51 | -- | 0.7979 | -- | 98.30 | 69.41 | 89.55 | -- | -30.34 | -- |
| Tsubota Laboratory Inc | 1.11bn | -303.08m | 11.13bn | 7.00 | -- | 7.88 | -- | 10.02 | -12.09 | -12.09 | 43.15 | 55.21 | 0.4899 | 1.60 | 5.16 | 158,704,300.00 | -13.37 | -- | -18.33 | -- | 52.59 | -- | -27.28 | -- | 2.57 | -24.64 | 0.0678 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
| PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 11.83bn | 22.00 | -- | 5.60 | -- | -- | -- | -- | -- | 58.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
| Nano Mrna Co Ltd | 52.10m | -821.00m | 11.87bn | 18.00 | -- | 3.88 | -- | 227.74 | -11.66 | -11.66 | 0.74 | 43.30 | 0.0102 | 7.01 | 1.56 | 2,894,445.00 | -16.13 | -24.16 | -17.89 | -25.17 | 80.72 | 84.69 | -1,575.81 | -600.70 | 8.17 | -- | 0.2662 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
| AnGes Inc | 521.96m | -9.80bn | 14.46bn | 145.00 | -- | 0.6128 | -- | 27.71 | -45.15 | -45.15 | 2.42 | 86.48 | 0.0174 | 0.2324 | 11.18 | 3,599,697.00 | -32.66 | -28.50 | -36.48 | -33.14 | 37.08 | 39.42 | -1,876.83 | -6,726.82 | 2.36 | -12.15 | 0.0672 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| Chordia Therapeutics Inc | 0.00 | -1.83bn | 15.14bn | 21.00 | -- | 3.63 | -- | -- | -31.95 | -31.95 | 0.00 | 61.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -500.25 | -- | -- | -- | -- | -918.09 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Medinet Co Ltd's reporting currency: Japanese Yen JPY
0.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 1.34m | 0.51% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 553.10k | 0.21% |
Data from 30 Sep 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
